EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Hepatocellular Carcinoma: Prevention, Diagnosis, and Treatment

Fei Feng, Yue Zhao

Medical Principles and Practice · 21.05.2024 · 33 (5) · 414-423

DOI: 10.1159/000539349 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Principles and Practice, online erschienen am 21.05.2024. Verfasst von Fei Feng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Ultrasound Medicine, The First Hospital of Lanzhou University, Lanzhou, China, ery_feifeng@lzu.edu.cn. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC), the most prevalent form of liver cancer globally, poses a substantial health burden. Influenced by risk factors such as hepatitis B or C virus infections, chronic consumption of alcohol, and metabolic dysfunction, its exact etiology likely involves a complex interplay between viral infection, hepatocyte mutations, and chronic liver diseases like cirrhosis and metabolic dysfunction-associated steatohepatitis, and demographic variables like sex, race, and age. Disease stage significantly impacts the prognosis of HCC. There is significant potential for life-saving and socioeconomic benefits through the implementation of surveillance programs and the introduction of low-cost screening measures for high-risk groups; these screening measures include ultrasound imaging and blood tests. Treatment options for HCC encompass liver resection, transplantation, transarterial chemoembolization, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. Despite therapeutic advances, treating advanced HCC remains challenging, emphasizing the need for continued efforts in prevention, early detection, and development of treatments to improve prognosis and long-term survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularHumansRisk FactorsPrognosis

Stichwörter der Autor:innen

Early detectionHepatocellular carcinomaPreventionRisk factorsUltrasound

Autor:innen und Institutionen

  • Ultrasound Medicine, The First Hospital of Lanzhou University, Lanzhou, China, ery_feifeng@lzu.edu.cn.
  • Department of Gastroenterology, The First Hospital of Lanzhou University, Key Laboratory for Gastrointestinal Disease of Gansu Province, Lanzhou, China.

Zitieren

APA

Feng, F., & Zhao, Y. (2024). Hepatocellular Carcinoma: Prevention, Diagnosis, and Treatment. Medical Principles and Practice, 33(5), 414-423. https://doi.org/10.1159/000539349

Vancouver

Feng F, Zhao Y. Hepatocellular Carcinoma: Prevention, Diagnosis, and Treatment. Medical Principles and Practice. 2024;33(5):414-423. doi:10.1159/000539349

BibTeX
@article{Feng2024,
  author = {Feng, Fei and Zhao, Yue},
  title = {Hepatocellular Carcinoma: Prevention, Diagnosis, and Treatment},
  journal = {Medical Principles and Practice},
  year = {2024},
  volume = {33},
  number = {5},
  pages = {414--423},
  doi = {10.1159/000539349}
}
Kostenlos starten →